Skip to main content
. 2022 Apr 8;2022:3796218. doi: 10.1155/2022/3796218

Figure 4.

Figure 4

Baicalein targeted inhibition of the SMYD2/RPS7 signaling pathway to inhibit lung cancer cells. (a) Baicalein inhibits the proliferation of lung cancer A549 and NCI-H1299 cell lines in differences dose. (b) Baicalein inhibits the invasion ability of lung cancer A549 and NCI-H1299 cell lines. (c) Baicalein inhibits the cloning ability of lung cancer A549 and NCI-H1299 cell lines. (d) qRT-PCR detection of Baicalein inhibits the expression of SMYD2 in lung cancer A549 and NCI-H1299 cells. (e) qRT-PCR detection of Baicalein inhibits the expression of RPS7 in lung cancer A549 and NCI-H1299 cells. ∗∗P < 0.01.